Cargando…
Gene signatures ESC, MYC and ERG-fusion are early markers of a potentially dangerous subtype of prostate cancer
BACKGROUND: Good prognostic tools for predicting disease progression in early stage prostate cancer (PCa) are still missing. Detection of molecular subtypes, for instance by using microarray gene technology, can give new prognostic information which can assist personalized treatment planning. The de...
Autores principales: | Rye, Morten Beck, Bertilsson, Helena, Drabløs, Finn, Angelsen, Anders, Bathen, Tone F, Tessem, May-Britt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147934/ https://www.ncbi.nlm.nih.gov/pubmed/25115192 http://dx.doi.org/10.1186/1755-8794-7-50 |
Ejemplares similares
-
A Balanced Tissue Composition Reveals New Metabolic and Gene Expression Markers in Prostate Cancer
por: Tessem, May-Britt, et al.
Publicado: (2016) -
Cholesterol synthesis pathway genes in prostate cancer are transcriptionally downregulated when tissue confounding is minimized
por: Rye, Morten Beck, et al.
Publicado: (2018) -
Presence of TMPRSS2-ERG is associated with alterations of the metabolic profile in human prostate cancer
por: Hansen, Ailin Falkmo, et al.
Publicado: (2016) -
The genes controlling normal function of citrate and spermine secretion are lost in aggressive prostate cancer and prostate model systems
por: Rye, Morten Beck, et al.
Publicado: (2022) -
SFRP4 gene expression is increased in aggressive prostate cancer
por: Sandsmark, Elise, et al.
Publicado: (2017)